Cox, Kristin E Turner, Michael A Lwin, Thinzar M Amirfakhri, Siamak Kelly, Kaitlyn J Hosseini, Mojgan Ghosh, Pradipta Obonyo, Marygorret Hoffman, Robert M Yazaki, Paul J
...
BackgroundGastric cancer poses a major diagnostic and therapeutic challenge as surgical resection provides the only opportunity for a cure. Specific labeling of gastric cancer could distinguish resectable and nonresectable disease and facilitate an R0 resection, which could improve survival.MethodsTwo patient-derived gastric cancer lines, KG8 and K...
Taylor, Annie E Hering, Moritz Elsegood, Mark RJ Teat, Simon J Weaver, George W Arroo, Randolph RJ Kaiser, Marcel Maeser, Pascal Bhambra, Avninder S
Human African trypanosomiasis, or sleeping sickness, is a neglected tropical disease caused by Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense and is invariably fatal unless treated. Current therapies present limitations in their application, parasite resistance, or require further clinical investigation for wider use. Our work, inf...
Fote, Gianna M Eapen, Vinay V Lim, Ryan G Yu, Clinton Salazar, Lisa McClure, Nicolette R McKnight, Jharrayne Nguyen, Thai B Heath, Marie C Lau, Alice L
...
Understanding the normal function of the Huntingtin (HTT) protein is of significance in the design and implementation of therapeutic strategies for Huntington's disease (HD). Expansion of the CAG repeat in the HTT gene, encoding an expanded polyglutamine (polyQ) repeat within the HTT protein, causes HD and may compromise HTT's normal activity contr...
Picart, Thiebaud Hervey-Jumper, Shawn
PurposeUnderstanding the complex bidirectional interactions between neurons and glioma cells could help to identify new therapeutic targets. Herein, the techniques and application of novel neuroscience tools implemented to study the complex interactions between brain and malignant gliomas, their results, and the potential therapeutic opportunities ...
Fazzari, Elisa Azizad, Daria J Yu, Kwanha Ge, Weihong Li, Matthew X Nano, Patricia R Kan, Ryan L Tum, Hong A Tse, Christopher Bayley, Nicholas A
...
Glioblastoma (GBM) is the deadliest form of primary brain tumor with limited treatment options. Recent studies have profiled GBM tumor heterogeneity, revealing numerous axes of variation that explain the molecular and spatial features of the tumor. Here, we seek to bridge descriptive characterization of GBM cell type heterogeneity with the function...
Carrasco-Zanini, Julia Pietzner, Maik Davitte, Jonathan Surendran, Praveen Croteau-Chonka, Damien C Robins, Chloe Torralbo, Ana Tomlinson, Christopher Grünschläger, Florian Fitzpatrick, Natalie
...
For many diseases there are delays in diagnosis due to a lack of objective biomarkers for disease onset. Here, in 41,931 individuals from the United Kingdom Biobank Pharma Proteomics Project, we integrated measurements of ~3,000 plasma proteins with clinical information to derive sparse prediction models for the 10-year incidence of 218 common and ...
Bermejo-Rodriguez, Camino Araos Henríquez, Joaquín Caligiuri, Giuseppina Teles, Sara Park, Youngkyu Evans, Anthony Barrera, Lawrence Neesse, Albrecht Grutzmann, Robert Aust, Daniela
...
Perturbation of cell polarity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) progression. Scribble (SCRIB) is a well characterized polarity regulator that has diverse roles in the pathogenesis of human neoplasms. To investigate the impact of SCRIB deficiency in PDAC development and progression, Scrib expression was genetically ablated in ...
Kliegman, Melinda Zaghlula, Manar Abrahamson, Susan Esensten, Jonathan H Wilson, Ross Urnov, Fyodor D Doudna, Jennifer A
Nineteen genetic therapies have been approved by the U.S. Food and Drug Administration (FDA) to date, a number that now includes the first CRISPR genome editing therapy for sickle cell disease, CASGEVY (exagamglogene autotemcel). This extraordinary milestone is widely celebrated because of the promise for future genome editing treatments of previou...
Jackovich, Alexandra Gitlitz, Barbara J Tiu-lim, Justin Wayne Wong Duddalwar, Vinay King, Kevin George El-Khoueiry, Anthony B Thomas, Jacob Stephen Tsao-Wei, Denice Quinn, David I Gill, Parkash S
...
ObjectivePatients with relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) after primary local therapy have low response rates with cetuximab, systemic chemotherapy or check point inhibitor therapy. Novel combination therapies with the potential to improve outcomes for patients with HNSCC is an area of high unmet need.MethodsThis i...
Lai, Thomas J Sun, Lu Li, Kevin Prins, Terry J Treger, Janet Li, Tie Sun, Matthew Z Nathanson, David A Liau, Linda M Lai, Albert
...
Glioblastoma (GBM) is the most common malignant primary brain tumor and remains incurable. Previous work has shown that systemic administration of Decitabine (DAC) induces sufficient expression of cancer-testis antigens (CTA) in GBM for targeting by adoptive T-cell therapy in vivo. However, the mechanisms by which DAC enhances immunogenicity in GBM...